Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) was $15.66 for the day, down -5.83% from the previous closing price of $16.63. In other words, the price has decreased by -$5.83 from its previous closing price. On the day, 0.65 million shares were traded.
Ratios:
Our analysis of CNTA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 21.52 and its Current Ratio is at 21.52. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.17.
On September 20, 2024, Morgan Stanley Upgraded its rating to Overweight which previously was Equal-Weight and also upped its target price recommendation from $11 to $26.
On September 19, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $33.B. Riley Securities initiated its Buy rating on September 19, 2024, with a $33 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 20 ’25 when SAHA SAURABH sold 55,000 shares for $15.93 per share. The transaction valued at 876,088 led to the insider holds 331,017 shares of the business.
SAHA SAURABH bought 55,000 shares of CNTA for $874,500 on Feb 20 ’25. On Feb 18 ’25, another insider, HUSSAIN IQBAL J, who serves as the General Counsel of the company, sold 6,000 shares for $16.18 each. As a result, the insider received 97,065 and left with 105,386 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 298.38 while its Price-to-Book (P/B) ratio in mrq is 4.13.
Stock Price History:
Over the past 52 weeks, CNTA has reached a high of $19.09, while it has fallen to a 52-week low of $7.75. The 50-Day Moving Average of the stock is -6.44%, while the 200-Day Moving Average is calculated to be 13.63%.
Shares Statistics:
A total of 131.66M shares are outstanding, with a floating share count of 79.75M. Insiders hold about 39.43% of the company’s shares, while institutions hold 55.19% stake in the company.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 4.0 analysts currently analyzing and rating the stock of Centessa Pharmaceuticals plc ADR (CNTA).The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.36 and low estimates of -$0.38.
Analysts are recommending an EPS of between -$1.22 and -$1.54 for the fiscal current year, implying an average EPS of -$1.43. EPS for the following year is -$1.55, with 6.0 analysts recommending between -$1.37 and -$1.77.
